Binding inhibition of angiogenic factors by heparan sulfate proteoglycans in aqueous humor: potential mechanism for maintenance of an avascular environment

被引:33
作者
Fannon, M
Forsten-Williams, K
Dowd, CJ
Freedman, DA
Folkman, J
Nugent, MA
机构
[1] Childrens Hosp, Dept Surg, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA
[4] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA
[5] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA
关键词
VEGF; endothelial cell; bFGF; heparin binding; computational model;
D O I
10.1096/fj.02-0935fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aqueous humor is a clear fluid, primarily a blood filtrate, which circulates through the anterior chamber of the eye and bathes the cornea. We explored the possibility that components in the aqueous humor play a direct part in maintaining the avascular environment of the cornea. We report here that heparan sulfate proteoglycan (HSPG) was found in bovine aqueous humor and that it directly inhibits binding of basic fibroblast growth factor and vascular endothelial growth factor to cell-surface heparan sulfate. We demonstrate that this holds true for all heparin binding proteins tested but not for epidermal growth factor, which does not bind heparin. Furthermore, we show, with mathematical modeling, that the concentration of HSPG in aqueous humor ( 4 mug/ml), when combined with the clearance of aqueous humor from the eye due to circulation, is sufficient to block the binding of heparin binding growth factors to corneal endothelium. This mechanism suggests a physiological process to control bioavailability of angiogenic growth factors in the cornea.
引用
收藏
页码:902 / +
页数:20
相关论文
共 50 条
[31]  
Namiki Mari, 1994, Nippon Ganka Gakkai Zasshi, V98, P334
[32]   ELEVATED LEVELS OF THE ANGIOGENIC PEPTIDE BASIC FIBROBLAST GROWTH-FACTOR IN URINE OF BLADDER-CANCER PATIENTS [J].
NGUYEN, M ;
WATANABE, H ;
BUDSON, AE ;
RICHIE, JP ;
FOLKMAN, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) :241-242
[33]  
NUGENT MA, 1993, CIRC RES, V73, P1051, DOI 10.1161/01.RES.73.6.1051
[34]   KINETICS OF BASIC FIBROBLAST GROWTH-FACTOR BINDING TO ITS RECEPTOR AND HEPARAN-SULFATE PROTEOGLYCAN - A MECHANISM FOR COOPERATIVITY [J].
NUGENT, MA ;
EDELMAN, ER .
BIOCHEMISTRY, 1992, 31 (37) :8876-8883
[35]  
NUGENT MA, 1994, INV OPHTHAL VIS SCI, V34, P3049
[36]   Treatment of cancer with anticoagulants: Rationale in the treatment of melanoma [J].
Ornstein, DL ;
Zacharski, LR .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2001, 73 (02) :157-161
[37]   REQUIREMENT OF HEPARAN-SULFATE FOR BFGF-MEDIATED FIBROBLAST GROWTH AND MYOBLAST DIFFERENTIATION [J].
RAPRAEGER, AC ;
KRUFKA, A ;
OLWIN, BB .
SCIENCE, 1991, 252 (5013) :1705-1708
[38]   ENDOTHELIAL CELL-DERIVED HEPARAN-SULFATE BINDS BASIC FIBROBLAST GROWTH-FACTOR AND PROTECTS IT FROM PROTEOLYTIC DEGRADATION [J].
SAKSELA, O ;
MOSCATELLI, D ;
SOMMER, A ;
RIFKIN, DB .
JOURNAL OF CELL BIOLOGY, 1988, 107 (02) :743-751
[39]   Corneal insult affects the production and distribution of FGF-2 within the lacrimal gland [J].
Schechter, J ;
Wallace, M ;
Carey, J ;
Chang, N ;
Trousdale, M ;
Wood, R .
EXPERIMENTAL EYE RESEARCH, 2000, 70 (06) :777-784
[40]   Thrombospondin-1, a natural inhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia [J].
Sheibani, N ;
Sorenson, CM ;
Cornelius, LA ;
Frazier, WA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 267 (01) :257-261